Skip to main content

Table 2 Standardized dataset for the cost-effectiveness models in rotavirus vaccination: demography and incidence (Sources: [4, 5, 7, 14, 15, 20, 26, 27])

From: Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

 

Afr

Sear

Amr

Eur

Notes

Total # of life births

1,496,200

3,427,800

140,110

190,000

 

Life expectancy at birth in years

54

66

73

80

average men & women

Population

34,255,722

141,822,276

5,486,685

16,500,000

 

% of population < 5 years

16.8%

16.8%

16.8%

6.1%

 

% urban

42%

23%

62%

100%

 

Infant mortality (< 1 year of age)

64

45

21

4

per 1000 life births

Mortality < 5 years

104

57

26

0.5

per 1000 life births/yr

Population < 5 years

5,736,373

17,399,197

730,913

1,000,000

 

Incidence mild rotavirus gastro-enteritis

     

   1st year after birth

1.4%

1.4%

1.4%

1.4%

in % per month

   2nd year after birth

0.57%

0.57%

0.57%

0.57%

in % per month

   3rd & 4th after birth

0.49%

0.49%

0.49%

0.49%

in % per month

Incidence of moderate

38.7%

38.7%

38.7%

33.1%

in % from mild

Incidence of severe

7.9%

7.9%

7.9%

12.1%

in % from moderate

Incidence of death

18.8%

12.5%

6.3%

0.05%

in % from severe

Incidence of nosocomial infections

33.3%

33.3%

33.3%

25%

% from severe (on top)